TTBB CAS 124750-51-2 Ịdị ọcha>96.0% (HPLC) Ụlọ ọrụ etiti Irbesartan

Nkọwa dị mkpirikpi:

Aha: 5- (4'-Bromomethyl-1,1'-Biphenyl-2-yl)-1-Triphenylmethyl-1H-Tetrazole

Ihe atụ: TTBB

CAS: 124750-51-2

Dị ọcha:> 96.0% (HPLC)

Ọdịdị: Ọcha ka ọ fọrọ nke nta ka ọ bụrụ ọcha ntụ ntụ

Ọkara nke Irbesartan (CAS: 138402-11-6)

E-Mail: alvin@ruifuchem.com   


Nkọwa ngwaahịa

Ngwaahịa ndị emetụtara

Mkpado ngwaahịa

Nkọwa:

Njirimara kemịkalụ:

Aha Chemical 5- (4'-Bromomethyl-1,1'-Biphenyl-2-yl) -1-Triphenylmethyl-1H-Tetrazole
Ụdị okwu TTBB;BBTT;5-[4'-Bromomethyl- (1,1'-Biphenyl) -2-yl] -1-Triphenylmethyltetrazole;N- (Triphenylmethyl) -5- (4'-Bromomethylbiphenyl-2-yl-) tetrazole;Olmesartan adịghị ọcha 12;Losartan Bromo N1-Trityl adịghị ọcha
Nọmba CAS 124750-51-2
Nọmba CAT RF-PI1878
Ọnọdụ Ahịa N'ahịa, Ike nrụpụta 150MT/Afọ
Usoro ihe omimi C33H25BrN4
Ibu molekụla 557.48
Ebe Na-agbaze 152.0 ~ 155.0 ℃
Njupụta 1.28±0.10 g/cm3
Ụdị Ruifu Chemical

Nkọwapụta:

Ihe Nkọwapụta
Ọdịdị Ọcha ka ọ fọrọ nke nta ka ọ bụrụ ọcha ntụ ntụ
Ụzọ ịdị ọcha / nyocha > 96.0% (HPLC)
Ọnwụ na ihicha <0.50%
adịghị ọcha A <2.00% (HPLC) 5- (4-Methyl-1,1-Biphenyl-2-yl) -1-Triphenylmethyl-1H-Tetrazole
adịghị ọcha B <2.00% 5- (4'.4'-Dibromomethyl-1,1-Biphenyl-2-yl) -1-Triphenylmethyl-1H-Tetrazole
Spectrum infrared Dabara na Ọdịdị
Nlele ọkọlọtọ Standardkpụrụ ụlọ ọrụ
Ojiji Ndị etiti nke Irbesartan (CAS: 138402-11-6);Olmesartan Medoxomil adịghị ọcha

Ngwungwu & Nchekwa:

ngwugwu: Kalama, Aluminom foil bag, 25kg / Cardboard Drum, ma ọ bụ dị ka ndị ahịa chọrọ

Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ìhè na mmiri mmiri

Uru:

1

Ajụjụ:

Ngwa:

5- (4'-Bromomethyl-1,1'-Biphenyl-2-yl) -1-Triphenylmethyl-1H-Tetrazole (TTBB) (CAS: 124750-51-2) bụ etiti nke Irbesartan (CAS: 138402-11). -6).A na-eji Irbesartan maka ọgwụgwọ ọbara mgbali elu yana nephropathy na-arịa ọrịa mamịrị yana serum creatinine na proteinuria dị elu (> 300 mg / ụbọchị) na ndị ọrịa nwere ụdị ọrịa shuga 2 na ọbara mgbali elu.A na-ejikwa Irbesartan mee ihe dị ka onye na-ahụ maka ahịrị nke abụọ na ọgwụgwọ nke conges.Irbesartan bụ onye na-anabata angiotensin II antagonist nke a na-ejikarị maka ọgwụgwọ ọbara mgbali elu.Emepụtara ya site na Sanofi Research (nke bụ akụkụ nke Sanofi-Aventis ugbu a).Sanofi-Aventis na Bristol-Myers Squibb jikọrọ aka na-ere ya n'okpuru aha azụmaahịa Aprovel, Karvea na Avapro.

Dee ozi gị ebe a ziga anyị ya